Effectiveness of [ 67 Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer.

Jessica Pougoue KetchemenFabrice Ngoh NjotuHanan BabekerStephen AhenkorahAnjong Florence TikumEmmanuel NwangeleNikita HenningFrederik CleerenHumphrey Fonge

Published in: European journal of nuclear medicine and molecular imaging (2024)

Cu]Cu-NOTA-trastuzumab is a promising theranostic agent against HER2-positive BC.

Keyphrases

positive breast cancer
aqueous solution
metal organic framework
epidermal growth factor receptor
photodynamic therapy
randomized controlled trial
systematic review
fluorescence imaging
metastatic breast cancer